Stockreport

UroGen Announces FDA Acceptance of its New Drug Application for UGN-102

UroGen Pharma Ltd. - Ordinary Shares  (URGN) 
Last urogen pharma ltd. - ordinary shares earnings: 3/2 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.urogen.com
PDF PDUFA goal date set for June 13, 2025UGN-102 would be the first FDA-approved medicine for LG-IR-NMIBC, if approved PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd [Read more]